PLX3397 KIT in Acral aNd mucOsal Melanoma

NCT02071940 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

7

Enrollment

OTHER

Sponsor class

Conditions

Malignant Melanoma

Interventions

DRUG: PLX3397

Sponsor

The Christie NHS Foundation Trust

Collaborators

[object Object]
[object Object]